πŸ›οΈ Verified NIH Record β€’ Updated 2026-07-30

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide (NCT07220759)

Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity and Type 2 Diabetes

πŸ”΅ Active, Not Recruiting Phase3 πŸ’Š Investigational Drug / Biologic Sponsor: Novo Nordisk A/S

🩺 Plain-English Summary (8th-Grade Level)

This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilintide is a new investigational medicine. Doctors may not yet prescribe cagrilintide. Participant will either get cagrilintide or placebo. Which treatment participant get is decided by chance. Participants are two times more likely to get cagrilintide than placebo. Like all medicines, the study medicine may have side effects. For each participant, the study will last for about 1 year and 6 months.

Who can join: Review the eligibility criteria below.

Location: Univ of Alabama_Birmingham β€” Birmingham, Alabama

Age range: 18 Years

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (67 Sites)

Showing the first 25 of 67 sites.

  • Univ of Alabama_Birmingham β€” Birmingham, Alabama
  • Chambliss Clinical Trials, LLC β€” Montgomery, Alabama
  • Noble Clinical Research β€” Tucson, Arizona
  • Scripps Whittier Diabetes Inst β€” La Jolla, California
  • Headlands Research CTR Lincoln β€” Lincoln, California
  • Pacific Clinical Studies β€” Los Alamitos, California
  • Walgreens - Store 4442 β€” Kissimmee, Florida
  • Optimal Research Sites β€” Orange City, Florida
  • Center for Diab,Obes & Metab β€” Pembroke Pines, Florida
  • Palm Beach Research Center β€” West Palm Beach, Florida
  • East West Med Res Inst β€” Honolulu, Hawaii
  • MediSphere Medical RC β€” Evansville, Indiana
  • Walgreens - Store 3915 β€” Las Vegas, Nevada
  • Chear Center LLC β€” The Bronx, New York
  • Centricity Res New Bern Multispeciality β€” New Bern, North Carolina
  • Accellacare β€” Wilmington, North Carolina
  • Spartanburg Medical Research β€” Spartanburg, South Carolina
  • Holston Medical Group_Bristol β€” Bristol, Tennessee
  • Velocity Clinical Res-Dallas β€” Dallas, Texas
  • TPMG Clinical Research β€” Newport News, Virginia
  • National Clin Res Inc. β€” Richmond, Virginia
  • Buenos Aires MΓ‘cula β€” Ciudad Autonoma de Buenos Aires, Buenos Aires
  • CICEMO- Consultorio de InvestigaciΓ³n ClΓ­nica EMO β€” Ciudad Autonoma de Buenos Aires, Buenos Aires
  • Centro Medico Dra. Laura Maffei e Investigacion ClΓ­nica Apli β€” Buenos Aires,
  • OCT Research ULC (dba Okanagan Clinical Trials) β€” Kelowna, British Columbia

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Overweight clinical trials

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—